bucladesine has been researched along with digoxin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Beuckelmann, D; Böhm, M; Brown, L; Erdmann, E; Feiler, G; Kemkes, B; Lorenz, B; Näbauer, M | 1 |
| Harnish, PP; Samuel, K | 1 |
| Buser, PT; Jasmin, G; Parmley, WW; Wikman-Coffelt, J; Wu, SY | 1 |
| Hamilton, BP; Hamlyn, JM; Laredo, J; Shah, JR | 1 |
| Clark, BJ; el-Masri, MA; Qazzaz, HM; Valdes, R | 1 |
7 other study(ies) available for bucladesine and digoxin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium.
Topics: 1-Methyl-3-isobutylxanthine; Adult; Bucladesine; Calcium; Cardiac Output, Low; Cardiotonic Agents; Colforsin; Digitoxin; Digoxin; Dobutamine; Histamine; Humans; In Vitro Techniques; Middle Aged; Myocardial Contraction; Myocardium; Receptors, Adrenergic, beta; Stimulation, Chemical | 1988 |
Pharmacologic manipulation of the flushing action of cerebrospinal fluid. Effect on CSF diatrizoate levels.
Topics: Acetazolamide; Aminophylline; Animals; Bucladesine; Carbachol; Cerebrospinal Fluid; Dexamethasone; Diatrizoate; Digoxin; Furosemide; Male; Premedication; Probenecid; Rats; Rats, Inbred Strains; Ritodrine; Salicylates; Salicylic Acid | 1988 |
Distinct modulation of myocardial performance, energy metabolism, and [Ca2+]i transients by positive inotropic drugs in normal and severely failing hamster hearts.
Topics: Amrinone; Animals; Blood Pressure; Bucladesine; Calcium; Cardiomyopathies; Cardiotonic Agents; Cricetinae; Digoxin; Disease Models, Animal; Dobutamine; Energy Metabolism; Heart Failure; Isoproterenol; Magnetic Resonance Spectroscopy; Mesocricetus; Myocardial Contraction; Oxygen Consumption; Phosphates; Phosphorylation | 1995 |
Different signaling pathways mediate stimulated secretions of endogenous ouabain and aldosterone from bovine adrenocortical cells.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biological Factors; Bucladesine; Cardenolides; Cattle; Cells, Cultured; Digoxin; Enzyme Inhibitors; Imidazoles; Ouabain; Pyridines; Receptor, Angiotensin, Type 2; Saponins; Signal Transduction; Tetradecanoylphorbol Acetate; Zona Glomerulosa | 1998 |
Human adrenal cells in culture produce both ouabain-like and dihydroouabain-like factors.
Topics: Adrenal Glands; Biological Factors; Bucladesine; Cardenolides; Cells, Cultured; Chromatography, High Pressure Liquid; Digoxin; Humans; Immune Sera; Immunoenzyme Techniques; Ouabain; Saponins; Sodium-Potassium-Exchanging ATPase | 2002 |